Johnson &amp; Johnson is pumping more money into heart care with a roughly $13 billion deal for Shockwave Medical, which specializes in technology that helps open clogged arteries.

The health care giant said Friday that it will spend $335 in cash for each share of Shockwave. The total deal value includes cash acquired.

Johnson & Johnson is pumping more money into heart care with a roughly $13 billion deal for Shockwave Medical, which specializes in technology that helps open…{ai:summary}<p>Johnson & Johnson buys Shockwave Medical for $13 billion, focusing on heart care technology. The deal includes $335 in cash per share. #health</p>

J&J to pump another $13B into its MedTech business with Shockwave deal

Loading...